Given that the marker profile used to identify NMBCs was the reciprocal of that used to define CLL cells, we further examined the relationship between prospectively defined NMBCs (measured as a proportion of mononuclear cells in the blood) and MRD (measured as a proportion of CD45+ leukocytes in the bone marrow). This evidence concerns the gene PTPRC and B-cell chronic lymphocytic leukemia.